Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Ghrelin and its promoter variant associated with cardiac hypertrophy

Abstract

The roles of ghrelin, a peptide hormone that has a role in regulating food intake and energy homeostasis, in the cardiovascular system have not yet been unambiguously established. We evaluated the association between plasma ghrelin concentrations and −501A>C single-nucleotide polymorphism (SNP) in the ghrelin gene 5′ flanking area and echocardiographic measurements in 1037 middle-aged subjects. Left ventricular mass index (LVMI) was calculated according to Devereux's method. The ambulatory blood pressure (BP) was recorded using the fully automatic SpaceLabs 90207 oscillometric unit. Results suggested that plasma ghrelin was not related to mean ambulatory BP values. However, the highest plasma ghrelin tertile was associated with increased intraventricular septum (P=0.043) and posterior ventricular wall (P=0.002) thicknesses as well as left ventricular mass (P=0.05). After adjustment for age, sex, body mass index and systolic BP, the association persisted between ghrelin tertiles and intraventricular septum (P=0.05) and posterior ventricular wall (P=0.001) thicknesses. The SNP −501A>C polymorphism was associated with LVMI after adjustments for age, sex and systolic BP. In conclusion, ghrelin and its promoter variant are associated with cardiac hypertrophy indexes independent of BP. Positive correlation between ghrelin levels and increased wall thickness parameters may reflect compensatory up-regulation of ghrelin concentrations or direct effects of ghrelin on myocardium. The effects of the SNP seem not to be mediated through its effects on ghrelin plasma levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–660.

    Article  CAS  PubMed  Google Scholar 

  2. Kojima M, Kangawa K . Ghrelin: structure and function. Physiol Rev 2005; 85: 495–522.

    Article  CAS  PubMed  Google Scholar 

  3. Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004; 62: 481–488.

    Article  CAS  PubMed  Google Scholar 

  4. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1483–R1487.

    Article  CAS  PubMed  Google Scholar 

  5. Li L, Zhang L, Pang Y, Pan C, Qi Y, Chen L et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin 2006; 27: 527–535.

    Article  PubMed  Google Scholar 

  6. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M . Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002; 40: 694–699.

    Article  CAS  PubMed  Google Scholar 

  7. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674–3679.

    Article  CAS  PubMed  Google Scholar 

  8. Vestergaard ET, Andersen NH, Hansen TK, Rasmussen LM, Moller N, Sorensen KE et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol 2007; 293: H3020–H3026.

    Article  CAS  PubMed  Google Scholar 

  9. Tesauro M, Schinzari F, Caramanti M, Lauro R, Cardillo C . Metabolic and cardiovascular effects of ghrelin. Int J Pept 2010 Epub 16 Mar 2010.

  10. Tritos NA, Kissinger KV, Manning WJ, Danias PG . Association between ghrelin and cardiovascular indexes in healthy obese and lean men. Clin Endocrinol (Oxf) 2004; 60: 60–66.

    Article  CAS  Google Scholar 

  11. Rodríguez A, Gómez-Ambrosi J, Catalán V, Becerril S, Sáinz N, Gil MJ et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 2010; 28: 560–567.

    Article  PubMed  Google Scholar 

  12. Baessler A, Kwitek AE, Fischer M, Koehler M, Reinhard W, Erdmann J et al. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA/KORA Augsburg Echocardiographic Substudy. Hypertension 2006; 47: 920–927.

    Article  CAS  PubMed  Google Scholar 

  13. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA . Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999; 245: 163–174.

    Article  CAS  PubMed  Google Scholar 

  14. Du Bois D, Du Bois EF . A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863–871.

    Article  CAS  Google Scholar 

  15. Vasunta RL, Kesäniemi YA, Ukkola O . Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status. J Hum Hypertens 2010; 24: 545–551.

    Article  CAS  PubMed  Google Scholar 

  16. Pöykkö SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O . Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546–2553.

    Article  PubMed  Google Scholar 

  17. Vartiainen J, Kesaniemi YA, Ukkola O . Sequencing analysis of ghrelin gene 5′ flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 2006; 55: 1420–1425.

    Article  CAS  PubMed  Google Scholar 

  18. Sahn DJ, DeMaria A, Kisslo J, Weyman A . The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  PubMed  Google Scholar 

  19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Gampo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.

    Article  CAS  PubMed  Google Scholar 

  20. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000; 23: 493–495.

    Article  CAS  PubMed  Google Scholar 

  21. Colao A, Marzullo P, Di Somma C, Lombardi G . Growth hormone and the heart. Clin Endocrinol (Oxf) 2001; 54: 137–154.

    Article  CAS  Google Scholar 

  22. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830–835.

    Article  CAS  PubMed  Google Scholar 

  23. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029–1037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pöykkö SM, Kellokoski E, Ukkola O, Kauma H, Paivansalo M, Kesaniemi YA et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006; 260: 43–52.

    Article  PubMed  Google Scholar 

  25. Berthold HK, Giannakidou E, Krone W, Trégouët DA, Gouni-Berthold I . Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease. Hypertens Res 2010; 33: 155–160.

    Article  CAS  PubMed  Google Scholar 

  26. Garcia EA, King P, Sidhu K, Ohgusu H, Walley A, Lecoeur C et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol 2009; 161: 307–315.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Medical Council of the Academy of Finland and the Finnish Foundation for Cardiovascular Research. We thank Markku Ikäheimo MD, PhD for the expert ultrasound examinations. We acknowledge the excellent technical assistance of, Ms Helena Kalliokoski, Ms Saija Kortetjärvi, Ms Sirpa Rannikko and Ms Liisa Mannermaa.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O Ukkola.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ukkola, O., Pääkkö, T. & Kesäniemi, Y. Ghrelin and its promoter variant associated with cardiac hypertrophy. J Hum Hypertens 26, 452–457 (2012). https://doi.org/10.1038/jhh.2011.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.51

Keywords

Search

Quick links